| Bharat B Langer, MD | |
|
1044 State St, Schenectady, NY 12307 | |
| (518) 370-1441 | |
| (518) 395-9431 |
| Full Name | Bharat B Langer |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 44 Years |
| Location | 1044 State St, Schenectady, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073579280 | NPI | - | NPPES |
| 02995513 | Medicaid | NY | |
| 331833 | Other | MEDICARE OSCAR | |
| 53099A | Other | NY | MEDICARE PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 222185 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Whitney M Young Jr Health Center Inc | 6507830031 | 12 |
News Archive
Speaker Nancy Pelosi issued the following statement today after the Obama Administration announced new guidance to make it easier for small business owners to take advantage of tax credits in the new health insurance reform law, including clarifying that a small business' substantial tax credit under reform will not be reduced if they also receive a state subsidy, and allowing them to receive tax credits for add-on dental and vision coverage in addition to regular health insurance
According to a new study the risk of suicide is not increased when adults start using antidepressants, and does in fact drop almost as soon as medication is begun.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
In today's headlines, continuing analysis of how the health law is faring in the courts and what the sweeping measure's future might look like.
› Verified 3 days ago
| Entity Name | Schenectady Family Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396711982 PECOS PAC ID: 1850280827 Enrollment ID: O20040325000143 |
News Archive
Speaker Nancy Pelosi issued the following statement today after the Obama Administration announced new guidance to make it easier for small business owners to take advantage of tax credits in the new health insurance reform law, including clarifying that a small business' substantial tax credit under reform will not be reduced if they also receive a state subsidy, and allowing them to receive tax credits for add-on dental and vision coverage in addition to regular health insurance
According to a new study the risk of suicide is not increased when adults start using antidepressants, and does in fact drop almost as soon as medication is begun.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
In today's headlines, continuing analysis of how the health law is faring in the courts and what the sweeping measure's future might look like.
› Verified 3 days ago
| Entity Name | Whitney M Young Jr Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417924762 PECOS PAC ID: 6507830031 Enrollment ID: O20040821000073 |
News Archive
Speaker Nancy Pelosi issued the following statement today after the Obama Administration announced new guidance to make it easier for small business owners to take advantage of tax credits in the new health insurance reform law, including clarifying that a small business' substantial tax credit under reform will not be reduced if they also receive a state subsidy, and allowing them to receive tax credits for add-on dental and vision coverage in addition to regular health insurance
According to a new study the risk of suicide is not increased when adults start using antidepressants, and does in fact drop almost as soon as medication is begun.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
In today's headlines, continuing analysis of how the health law is faring in the courts and what the sweeping measure's future might look like.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bharat B Langer, MD 1462 Erie Blvd, Suite 2, Schenectady, NY 12305-1026 Ph: (518) 243-1500 | Bharat B Langer, MD 1044 State St, Schenectady, NY 12307 Ph: (518) 370-1441 |
News Archive
Speaker Nancy Pelosi issued the following statement today after the Obama Administration announced new guidance to make it easier for small business owners to take advantage of tax credits in the new health insurance reform law, including clarifying that a small business' substantial tax credit under reform will not be reduced if they also receive a state subsidy, and allowing them to receive tax credits for add-on dental and vision coverage in addition to regular health insurance
According to a new study the risk of suicide is not increased when adults start using antidepressants, and does in fact drop almost as soon as medication is begun.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
In today's headlines, continuing analysis of how the health law is faring in the courts and what the sweeping measure's future might look like.
› Verified 3 days ago
Dr. Christopher Scott Burky, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 31 Lafayette St, Schenectady, NY 12305 Phone: 518-381-8911 Fax: 518-377-4292 | |
Dr. Arun Kumar Dhingra, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1101 Nott St, Dept. Of Psychiatry, Schenectady, NY 12308 Phone: 518-243-4154 Fax: 518-243-4170 | |
Peeyush Mittal, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1044 State St, Schenectady, NY 12307 Phone: 518-370-1441 Fax: 518-395-9431 | |
Dr. Naseer A Chowdhrey, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2125 River Rd, Suite 303, Schenectady, NY 12309 Phone: 518-381-1800 Fax: 518-381-1801 | |
Beatrice M Kovasznay, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1101 Nott St, Dept Of Psychiatry, Schenectady, NY 12308 Phone: 518-243-4162 | |
Yousuf N. Ahmad, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1101 Nott St, Schenectady, NY 12308 Phone: 518-243-4000 |